NASDAQ:ELOS

Syneron Medical (ELOS) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
$11.00
$11.00
50-Day Range
N/A
52-Week Range
$6.18
$11.43
Volume
N/A
Average Volume
562,777 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
ELOS stock logo

About Syneron Medical Stock (NASDAQ:ELOS)

Syneron Medical Ltd. is engaged in the manufacture, research, development, marketing and sale of equipment for the aesthetic medical industry and systems for dermatologists, plastic surgeons and other qualified practitioners. The Company's aesthetic medical products are based on its various technologies, including Electro-Optical Synergy (ELOS) technology, which uses the synergy between electrical energy, including radiofrequency (RF) energy, and optical energy to provide aesthetic medical treatments. The Company's products target a range of non-invasive aesthetic medical procedures, including hair removal, wrinkle reduction, tattoo removal, rejuvenation of the skin's appearance through the treatment of superficial benign vascular and pigmented lesions, acne treatment, treatment of leg veins, treatment for the temporary reduction in the appearance of cellulite and thigh circumference, ablation and resurfacing of the skin, and laser-assisted lipolysis.

ELOS Stock News Headlines

Apax Global Alpha Ltd (APAX)
Elos Medtech AB Class B ELOS B
Better than Bitcoin? The Biotech Stock with 46,751% Potential
4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.
Syneron Medical Stock Hits New 52-Week Low (ELOS)
Elos Medtech AB Series B
Syneron Hires Finance Chief
Better than Bitcoin? The Biotech Stock with 46,751% Potential
4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.
Syneron Medical Stock Hits New 52-Week High (ELOS)
See More Headlines
Receive ELOS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Syneron Medical and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
8/04/2016
Today
4/25/2024

Industry, Sector and Symbol

Sector
N/A
Industry
N/A
Sub-Industry
N/A
Current Symbol
NASDAQ:ELOS
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
10 Best Stocks to Own in 2024 Cover

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio.

Get This Free Report

Key Executives

  • Shimon Eckhouse Ph.D.
    Chairman of the Board
  • Amit Meridor
    Chief Executive Officer

  • Bio & Compensation - 
  • Hugo Goldman
    Chief Financial Officer

  • Bio & Compensation - 
  • Erik Dowell
    Vice President-North America
  • William Griffing
    Chief Executive Officer - Syneron Candela North America
  • Shlomo Alkalay
    Chief Operating Officer
  • Lisa A. Soderquist
    Chief Human Resource Officer

  • Bio & Compensation - 
  • Robert Ruck
    Executive Vice President, Asia Pacific
  • Robert Fielitz
    Vice President and Managing Director of Europe, Middle East and Africa
  • Sarit Soccary Ben-Yochanan
    Vice President - Business Development & Strategy

ELOS Stock Analysis - Frequently Asked Questions

How were Syneron Medical's earnings last quarter?

Syneron Medical Ltd (NASDAQ:ELOS) announced its quarterly earnings results on Thursday, August, 4th. The medical equipment provider reported $0.09 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.06 by $0.03. The medical equipment provider earned $75 million during the quarter, compared to analyst estimates of $75.72 million. The business's revenue for the quarter was up 2.0% compared to the same quarter last year. During the same period last year, the company earned $0.07 earnings per share.

What other stocks do shareholders of Syneron Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Syneron Medical investors own include Micron Technology (MU), Advanced Micro Devices (AMD), BIOLASE (BIOL), Cisco Systems (CSCO), Freeport-McMoRan (FCX), Gilead Sciences (GILD), Lannett (LCI), Rite Aid (RAD), Ambarella (AMBA) and Citigroup (C).

This page (NASDAQ:ELOS) was last updated on 4/25/2024 by MarketBeat.com Staff

From Our Partners